Oragenics Raises CEO Salary, Awards Stock Options to Executives and Directors
I'm PortAI, I can summarize articles.
Oragenics Inc. announced changes in executive and director compensation. CEO Janet Huffman's salary will increase by 5% to $341,250, effective January 1, 2026, with a $110,500 bonus. She also received stock options for 250,000 shares at $0.93 each, vesting over three years. Non-Employee Directors received options for 125,000 shares, vesting immediately. Natasha Giordano, a new board member, received a $30,000 stock option, also vesting immediately. This information was published via the SEC's EDGAR system.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments